Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Hybrid Experimental and in silico Platform for ITPK1 Chemical Probe Discovery.

SLAS discovery : advancing life sciences R & D·2026
Same author

RNA-DNA Fusomer Fibers With Customizable Physicochemical, Mechanical, and Biological Properties for Next-Generation Therapeutics.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Human neutrophilic cells express anti-inflammatory EBI3 in response to Neisseria meningitidis.

Journal of neuroimmunology·2026
Same author

Integrating AI in Medicinal Chemistry for Accelerated Drug Discovery: A Comprehensive SAR (CSAR) Optimization Strategy and Discovery of Potent ALDH3A1 Inhibitors.

Journal of medicinal chemistry·2026
Same author

The C-type lectin receptor mincle is functionally expressed by murine bone cells and can mediate inflammatory osteoblast responses to Staphylococcus aureus.

Bone·2026
Same author

Corrigendum to "The C-type lectin receptor mincle is functionally expressed by murine bone cells and can mediate inflammatory osteoblast responses to Staphylococcus aureus" [Bone volume 203 February 2026, 117689].

Bone·2026

Related Experiment Video

Updated: Feb 22, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

4.0K

Programmable Nucleic Acid Based Polygons with Controlled Neuroimmunomodulatory Properties for Predictive QSAR

Morgan Brittany Johnson1, Justin R Halman2, Emily Satterwhite2

  • 1Department of Biological Sciences, University of North Carolina at Charlotte, 9201 University City Boulevard, Charlotte, NC, 28223, USA.

Small (Weinheim an Der Bergstrasse, Germany)
|September 19, 2017
PubMed
Summary

Researchers developed 16 programmable RNA and DNA nanostructures for therapy. Their immune response can be tuned, with molecular weight and stability predicting activity, enabling predictable immunomodulatory nanoparticle design.

Keywords:
QSARRNA and DNA nanoparticlesRNA nanotechnologyRNA polygonsimmunologyself-assembly

More Related Videos

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

10.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

Related Experiment Videos

Last Updated: Feb 22, 2026

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity
08:16

Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity

Published on: September 21, 2021

4.0K
Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

10.0K
Predictive Immune Modeling of Solid Tumors
08:50

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

7.6K

Area of Science:

  • Biotechnology
  • Nanotechnology
  • Immunology

Background:

  • Therapeutic RNA nanotechnology is a rapidly growing interdisciplinary field.
  • Programmable RNA nanostructures offer advantages for targeted therapies but require understanding of their immunomodulatory potential.
  • Assessing and controlling the immunostimulatory properties of nanotherapeutics is crucial for maximizing therapeutic benefits and minimizing complications.

Purpose of the Study:

  • To present 16 novel, configurable nucleic acid-based polygonal nanoparticle platforms.
  • To demonstrate the tunability of immunostimulatory properties in these nanostructures.
  • To establish design principles for nanoparticles with predictable immunomodulatory activity.

Main Methods:

  • Development of 16 programmable RNA and/or DNA polygonal nanoparticle platforms using Watson-Crick interactions.
  • Experimental tuning of immunostimulatory properties to achieve desired immune responses or lack thereof.
  • Quantitative structure-activity relationship (QSAR) modeling to correlate nanoparticle properties with immunomodulatory activity.

Main Results:

  • The study introduces 16 novel self-assembling nucleic acid nanostructures.
  • Immunostimulatory properties of these nanostructures were successfully tuned.
  • QSAR modeling identified molecular weight, melting temperature, and half-life as key predictors of immunomodulatory activity.

Conclusions:

  • A new library of highly configurable RNA and DNA nanostructures has been developed.
  • These platforms allow for predictable control over immunomodulatory activity.
  • The findings provide fundamental guidelines for designing next-generation nanotherapeutics with tailored immune responses.